Israeli Health Care Expenditure Data

25 May 1997

Israeli national health service spending rose 3% per capita in 1995,with private spending per capita up 4%. Indications are that 1996 spending increased 2% per head.

1995's national health spending reached 8.1% of Gross Domestic Product, including net taxes on imports. Since the National Health Insurance Law took effect at the start of 1995, the health tax, levied on the insured, has substituted the relevant membership fees paid directly to the sick funds. However, total national health spending is independent of institutional arrangements for health service financing.

1995 saw no outstanding changes by operating sector in the components of health spending. The sick funds supplied 44% of the service, and the share taken by government institutions (eg hospitals, clinics and regional health bureaux) reached 21%. 12% of services were supplied by other non-profit institutions such as Hadassah, Magen David Adom, etc, and the value of service supplied by commercial groups (dentists, other private doctors and hospitals, plus medicines and medical equipment sold commercially) is put at 23% of the total.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight